Researchers at University of California San Diego have received a $23.6 million award from ARPA-H to develop a groundbreaking approach for selecting cancer treatments. The project, titled ‘Dynamic Digital Tumors for Precision Oncology,’ aims to transform cancer care with AI-powered tools that predict therapy outcomes and tumor evolution. These Drug Recommender Engines (DREs) will enhance […]
Category: precision oncology
Tempus Presents 10 Abstracts at 2025 ASCO Annual Meeting
Precision oncology company Tempus has announced the acceptance of 10 abstracts for presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. As a leader in the field, Tempus focuses on utilizing advanced technology and data-driven insights to improve cancer treatment and patient outcomes. The company’s contributions at the upcoming meeting highlight its […]
